Tumor-infiltrating lymphocytes (TILs) have been established as a robust prognostic biomarker in breast cancer, with emerging utility in predicting treatment response in the adjuvant and neoadjuvant settings. In this study, the role of TILs in predicting overall survival and progression-free interval was evaluated in two independent cohorts of breast cancer from the Cancer Genome Atlas (TCGA BRCA) and the Carolina Breast Cancer Study (UNC CBCS). We utilized machine learning and computer vision algorithms to characterize TIL infiltrates in digital whole-slide images (WSIs) of breast cancer stained with hematoxylin and eosin (H&E). Multiple parameters were used to characterize the global abundance and spatial features of TIL infiltrates. Univa...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
Tumor-infiltrating lymphocytes (TILs) provide prognostic value in invasive breast cancer and guideli...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Abstract Tumor-infiltrating lymphocytes (TILs) have been recognized as key players in the tumor micr...
In estrogen-receptor-positive, HER2-negative (ER+HER2−) breast cancer, higher levels of tumor infilt...
This study aimed to explore the prognostic impact of spatial distribution of tumor-infiltrating lymp...
While tumor infiltration by CD8+ T cells is now widely accepted to predict outcomes, the clinical si...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
Tumor-infiltrating lymphocytes (TILs) provide prognostic value in invasive breast cancer and guideli...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
Abstract Tumor-infiltrating lymphocytes (TILs) have been recognized as key players in the tumor micr...
In estrogen-receptor-positive, HER2-negative (ER+HER2−) breast cancer, higher levels of tumor infilt...
This study aimed to explore the prognostic impact of spatial distribution of tumor-infiltrating lymp...
While tumor infiltration by CD8+ T cells is now widely accepted to predict outcomes, the clinical si...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
Tumor-infiltrating lymphocytes (TILs) provide prognostic value in invasive breast cancer and guideli...